Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Booster met zelfde of ander type vaccin tegen COVID-19 is effectief
jun 2022 | Vaccinatie, Virale infecties